Skip Nav Destination
Issues
1 June 2020
-
Cover Image
Cover Image
![issue cover]()
The cover shows distribution of a fluorescently labeled antibody (green) in a tumor cell nest after systemic administration (i.e., in vivo immunohistochemistry to trace drug delivery in human tumors) and illustrates that the binding-site barrier is real. For details, see the article by Lu and colleagues on page 2582 of this issue.Close Modal - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
Review
Perspectives
Design and Conduct of Early Clinical Studies of Immunotherapy: Recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies 2019 (MDICT)
Martin Smoragiewicz; Alex A. Adjei; Emiliano Calvo; Josep Tabernero; Aurélien Marabelle; Christophe Massard; Jun Tang; Elisabeth G.E. de Vries; Jean-Yves Douillard; Lesley Seymour; for the task force on Methodology for the Development of Innovative Cancer Therapies
Clinical Trials: Targeted Therapy
Author Choice
BRAF-Mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal Cancer
Gary Middleton; Yiqun Yang; Catarina D. Campbell; Thierry André; Chloe E. Atreya; Jan H.M. Schellens; Takayuki Yoshino; Johanna C. Bendell; Antoine Hollebecque; Autumn J. McRee; Salvatore Siena; Michael S. Gordon; Josep Tabernero; Rona Yaeger; Peter J. O'Dwyer; Filip De Vos; Eric Van Cutsem; John M. Millholland; Jan C. Brase; Fatima Rangwala; Eduard Gasal; Ryan B. Corcoran
Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)
Neesha C. Dhani; Hal W. Hirte; Lisa Wang; Julia V. Burnier; Angela Jain; Marcus O. Butler; Stephen Welch; Gini F. Fleming; Jean Hurteau; Koji Matsuo; Daniela Matei; Waldo Jimenez; Carolyn Johnston; Mihaela Cristea; Katia Tonkin; Prafull Ghatage; Stephanie Lheureux; Anjali Mehta; Judy Quintos; Qian Tan; Suzanne Kamel-Reid; Olga Ludkovski; Ming-Sound Tsao; John J. Wright; Amit M. Oza
Author Choice
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study
Wassim Abida; David Campbell; Akash Patnaik; Jeremy D. Shapiro; Brieuc Sautois; Nicholas J. Vogelzang; Eric G. Voog; Alan H. Bryce; Ray McDermott; Francesco Ricci; Julie Rowe; Jingsong Zhang; Josep Maria Piulats; Karim Fizazi; Axel S. Merseburger; Celestia S. Higano; Laurence E. Krieger; Charles J. Ryan; Felix Y. Feng; Andrew D. Simmons; Andrea Loehr; Darrin Despain; Melanie Dowson; Foad Green; Simon P. Watkins; Tony Golsorkhi; Simon Chowdhury
A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid Tumors
Taofeek K. Owonikoko; R. Donald Harvey; Bradley Carthon; Zhengjia Chen; Colleen Lewis; Hanna Collins; Chao Zhang; David H. Lawson; Olatunji B. Alese; Mehmet Asim Bilen; Gabriel L. Sica; Conor E. Steuer; Walid L. Shaib; Christina Wu; Wayne B. Harris; Mehmet Akce; Ragini R. Kudchagkar; Bassel F. El-Rayes; Sagar Lonial; Suresh S. Ramalingam; Fadlo Raja Khuri
Clinical Trials: Immunotherapy
Author Choice
Patient-Reported Outcomes from the Phase III Randomized IMmotion151 Trial: Atezolizumab + Bevacizumab versus Sunitinib in Treatment-Naïve Metastatic Renal Cell Carcinoma
Michael B. Atkins; Brian I. Rini; Robert J. Motzer; Thomas Powles; David F. McDermott; Cristina Suarez; Sergio Bracarda; Walter M. Stadler; Frede Donskov; Howard Gurney; Stephane Oudard; Motohide Uemura; Elaine T. Lam; Carsten Grüllich; Caroleen Quach; Susheela Carroll; Beiying Ding; Qian (Cindy) Zhu; Elisabeth Piault-Louis; Christina Schiff; Bernard Escudier
Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer
G. Travis Clifton; Diane Hale; Timothy J. Vreeland; Annelies T. Hickerson; Jennifer K. Litton; Gheath Alatrash; Rashmi K. Murthy; Na Qiao; Anne V. Philips; Jason J. Lukas; Jarrod P. Holmes; George E. Peoples; Elizabeth A. Mittendorf
Author Choice
First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20+ Non-Hodgkin Lymphomas
Ajay K. Gopal; Ronald Levy; Roch Houot; Sandip P. Patel; Leslie Popplewell; Caron Jacobson; Xinmeng J. Mu; Shibing Deng; Keith A. Ching; Ying Chen; Craig B. Davis; Bo Huang; Kolette D. Fly; Aron Thall; Adrian Woolfson; Nancy L. Bartlett
Precision Medicine and Imaging
Author Choice
MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer
Ibiayi Dagogo-Jack; Satoshi Yoda; Jochen K. Lennerz; Adam Langenbucher; Jessica J. Lin; Marguerite M. Rooney; Kylie Prutisto-Chang; Audris Oh; Nathaniel A. Adams; Beow Y. Yeap; Emily Chin; Andrew Do; Hetal D. Marble; Sara E. Stevens; Subba R. Digumarthy; Ashish Saxena; Rebecca J. Nagy; Cyril H. Benes; Christopher G. Azzoli; Michael S. Lawrence; Justin F. Gainor; Alice T. Shaw; Aaron N. Hata
Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion BRCA Mutations among Patients with Advanced Solid Tumors
Neelima Vidula; Thereasa A. Rich; Oliver Sartor; Jennifer Yen; Aaron Hardin; Tracy Nance; Michael B. Lilly; Mohammad Amin Nezami; Sandip P. Patel; Benedito A. Carneiro; Alice C. Fan; Adam M. Brufsky; Barbara A. Parker; Benjamin B. Bridges; Neeraj Agarwal; Benjamin L. Maughan; Victoria M. Raymond; Stephen R. Fairclough; Richard B. Lanman; Aditya Bardia; Massimo Cristofanilli
Author Choice
Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer
Heather A. Parsons; Justin Rhoades; Sarah C. Reed; Gregory Gydush; Priyanka Ram; Pedro Exman; Kan Xiong; Christopher C. Lo; Tianyu Li; Mark Fleharty; Gregory J. Kirkner; Denisse Rotem; Ofir Cohen; Fangyan Yu; Mariana Fitarelli-Kiehl; Ka Wai Leong; Melissa E. Hughes; Shoshana M. Rosenberg; Laura C. Collins; Kathy D. Miller; Brendan Blumenstiel; Lorenzo Trippa; Carrie Cibulskis; Donna S. Neuberg; Matthew DeFelice; Samuel S. Freeman; Niall J. Lennon; Nikhil Wagle; Gavin Ha; Daniel G. Stover; Atish D. Choudhury; Gad Getz; Eric P. Winer; Matthew Meyerson; Nancy U. Lin; Ian Krop; J. Christopher Love; G. Mike Makrigiorgos; Ann H. Partridge; Erica L. Mayer; Todd R. Golub; Viktor A. Adalsteinsson
Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer
Romualdo Barroso-Sousa; Tanya E. Keenan; Sonia Pernas; Pedro Exman; Esha Jain; Ana C. Garrido-Castro; Melissa Hughes; Brittany Bychkovsky; Renato Umeton; Janet L. Files; Neal I. Lindeman; Laura E. MacConaill; F. Stephen Hodi; Ian E. Krop; Deborah Dillon; Eric P. Winer; Nikhil Wagle; Nancy U. Lin; Elizabeth A. Mittendorf; Eliezer M. Van Allen; Sara M. Tolaney
Predicting Therapeutic Antibody Delivery into Human Head and Neck Cancers
Guolan Lu; Shayan Fakurnejad; Brock A. Martin; Nynke S. van den Berg; Stan van Keulen; Naoki Nishio; Ashley J. Zhu; Stefania U. Chirita; Quan Zhou; Rebecca W. Gao; Christina S. Kong; Nancy Fischbein; Mrudula Penta; Alexander D. Colevas; Eben L. Rosenthal
CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer
Farzana A. Faisal; Sanjana Murali; Harsimar Kaur; Thiago Vidotto; Liana B. Guedes; Daniela Correia Salles; Vishal Kothari; Jeffrey J. Tosoian; Sumin Han; Daniel H. Hovelson; Kevin Hu; Daniel E. Spratt; Alexander S. Baras; Scott A. Tomlins; Edward M. Schaeffer; Tamara L. Lotan
Translational Cancer Mechanisms and Therapy
Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14–Mutant NSCLC
Gonzalo Recondo; Magda Bahcall; Liam F. Spurr; Jianwei Che; Biagio Ricciuti; Giulia C. Leonardi; Ying-Chun Lo; Yvonne Y. Li; Giuseppe Lamberti; Tom Nguyen; Marina S.D. Milan; Deepti Venkatraman; Renato Umeton; Cloud P. Paweletz; Adem Albayrak; Andrew D. Cherniack; Kristin S. Price; Stephen R. Fairclough; Mizuki Nishino; Lynette M. Sholl; Geoffrey R. Oxnard; Pasi A. Jänne; Mark M. Awad
Local Intracerebral Immunomodulation Using Interleukin-Expressing Mesenchymal Stem Cells in Glioblastoma
Malte Mohme; Cecile L. Maire; Ulf Geumann; Simon Schliffke; Lasse Dührsen; Krystian Fita; Nuray Akyüz; Mascha Binder; Manfred Westphal; Christine Guenther; Katrin Lamszus; Felix G. Hermann; Nils Ole Schmidt
Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer
Adam J. Schoenfeld; Joseph M. Chan; Daisuke Kubota; Hiroki Sato; Hira Rizvi; Yahya Daneshbod; Jason C. Chang; Paul K. Paik; Michael Offin; Maria E. Arcila; Monika A. Davare; Ujwal Shinde; Dana Pe'er; Natasha Rekhtman; Mark G. Kris; Romel Somwar; Gregory J. Riely; Marc Ladanyi; Helena A. Yu
Determining the Optimal Adjuvant Therapy for Improving Survival in Elderly Patients with Glioblastoma: A Systematic Review and Network Meta-analysis
Farshad Nassiri; Shervin Taslimi; Justin Z. Wang; Jetan H. Badhiwala; Tatyana Dalcourt; Nazanin Ijad; Neda Pirouzmand; Saleh Almenawer; Roger Stupp; Gelareh Zadeh
Detection of Molecular Signatures of Homologous Recombination Deficiency in Prostate Cancer with or without BRCA1/2 Mutations
Zsofia Sztupinszki; Miklos Diossy; Marcin Krzystanek; Judit Borcsok; Mark M. Pomerantz; Viktoria Tisza; Sandor Spisak; Orsolya Rusz; István Csabai; Matthew L. Freedman; Zoltan Szallasi
Author Choice
Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation
Chao Liu; Sayed H. Sadat; Koji Ebisumoto; Akihiro Sakai; Bharat A. Panuganti; Shuling Ren; Yusuke Goto; Sunny Haft; Takahito Fukusumi; Mizuo Ando; Yuki Saito; Theresa Guo; Pablo Tamayo; Huwate Yeerna; William Kim; Jacqueline Hubbard; Andrew B. Sharabi; J. Silvio Gutkind; Joseph A. Califano
Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis
Melinda L. Telli; Charles Chu; Sunil S. Badve; Shaveta Vinayak; Daniel P. Silver; Steven J. Isakoff; Virginia Kaklamani; William Gradishar; Vered Stearns; Roisin M. Connolly; James M. Ford; Joshua J. Gruber; Sylvia Adams; Judy Garber; Nadine Tung; Chris Neff; Ryan Bernhisel; Kirsten M. Timms; Andrea L. Richardson
A Chimeric Signal Peptide–Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell–Specific Apoptosis
Sok-Hyong Lee; Fatima Khwaja Rehman; Kari C. Tyler; Bing Yu; Zhaobin Zhang; Satoru Osuka; Abdessamad Zerrouqi; Milota Kaluzova; Costas G. Hadjipanayis; Richard D. Cummings; Jeffrey J. Olson; Narra S. Devi; Erwin G. Van Meir
ATP-Citrate Lyase Epigenetically Potentiates Oxidative Phosphorylation to Promote Melanoma Growth and Adaptive Resistance to MAPK Inhibition
Weinan Guo; Jinyuan Ma; Yuqi Yang; Sen Guo; Weigang Zhang; Tao Zhao; Xiuli Yi; Huina Wang; Shiyu Wang; Yu Liu; Wei Dai; Xuguang Chen; Qiong Shi; Gang Wang; Tianwen Gao; Chunying Li
Corrections
Advertisement
